Pheochromocytomas are
neural crest-derived tumors that occur mostly sporadically, but may also be part of inherited syndromes. The molecular pathogenesis of sporadic
pheochromocytomas remains unknown. Recently, the susceptibility gene for familial
paraganglioma syndrome, a disorder embryologically related to
pheochromocytomas, was characterized and shown to encode the small subunit of
succinate dehydrogenase (SDHD), which is part of the mitochondrial complex II. This complex regulates
oxygen-sensing signals. Importantly, hypoxic signals also appear to be related to the pathogenesis of
pheochromocytomas associated with
von Hippel-Lindau syndrome. We sequenced the entire coding region of the SDHD gene in a series of
pheochromocytomas. Although we did not find mutations in the gene, we identified a new intronic single nucleotide polymorphism in 15% of the samples (g.97739A-->G). We also confirmed the existence of a sequence highly homologous to the SDHD
complementary DNA in chromosome 1p34--36, a region commonly deleted in
pheochromocytomas. Full analysis of this sequence revealed a heterozygous single base substitution in 70% of our samples that was also present in the germline. This sequence does not appear to be transcribed and is probably a processed pseudogene. Therefore, despite its chromosomal location, it is unlikely that this sequence is a target of loss of heterozygosity in
pheochromocytomas. In conclusion, mutations of the SDHD gene are not a common event in this series of sporadic
pheochromocytomas. The existence of SDHD pseudogenes should be considered when analyzing
complementary DNA-based samples.